Cargando…
Clinical and serological evaluation of a novel CENP-A peptide based ELISA
INTRODUCTION: Anti-centromere antibodies (ACA) are useful biomarkers in the diagnosis of systemic sclerosis (SSc). ACA are found in 20 to 40% of SSc patients and, albeit with lower prevalence, in patients with other systemic autoimmune rheumatic diseases. Historically, ACA were detected by indirect...
Autores principales: | Mahler, Michael, Maes, Liesbeth, Blockmans, Daniel, Westhovens, Rene, Bossuyt, Xavier, Riemekasten, Gabriela, Schneider, Sandra, Hiepe, Falk, Swart, Andreas, Gürtler, Irmgard, Egerer, Karl, Fooke, Margrit, Fritzler, Marvin J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911886/ https://www.ncbi.nlm.nih.gov/pubmed/20487535 http://dx.doi.org/10.1186/ar3029 |
Ejemplares similares
-
Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus
por: Mahler, Michael, et al.
Publicado: (2007) -
Current Concepts and Future Directions for the Assessment of Autoantibodies to Cellular Antigens Referred to as Anti-Nuclear Antibodies
por: Mahler, Michael, et al.
Publicado: (2014) -
Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus
por: Biesen, Robert, et al.
Publicado: (2011) -
AIT test has no problem in the detection of anti-ribosomal P – authors' response
por: Mahler, Michael, et al.
Publicado: (2009) -
The changing landscape of the clinical value of the PM/Scl autoantibody system
por: Mahler, Michael, et al.
Publicado: (2009)